Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

U.S. patent issued for Sertoli cell technology

Dec. 23, 1997

Anandamide amidase inhibitors reported in patent literature

Dec. 23, 1997

Dopamine synthesis and release inhibitors discovered at AHP

Dec. 23, 1997

Novel nicotinic ligand discovered by British university researchers

Dec. 22, 1997

Pharmacological characterization of LY-344864, a selective 5-HT1F receptor agonist

Dec. 22, 1997

Prevention of neurodegeneration in Parkinson's disease reported

Dec. 22, 1997

Naramig available in Germany

Dec. 19, 1997

European approvals for Edronax

Dec. 19, 1997

Patient accrual in Cerestat trials will not resume

Dec. 19, 1997

Synthelabo to market milnacipran in Europe and certain other markets

Dec. 19, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...